|
Aytu Biopharma Inc (NASDAQ: AYTU) |
|
Aytu Biopharma Inc
AYTU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Aytu Biopharma Inc's sales fell
by -26.62 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2077
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Aytu Biopharma Inc realized net income compared to net loss a year ago in I. Quarter 2024
• More on AYTU's Growth
|
|
Aytu Biopharma Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 97.95 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on AYTU's Valuation
|
|
|
|
|
Aytu Biopharma Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 97.95 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.19.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
Aytu Biopharma Inc Price to Book Ratio is at 0.47 lower than Industry Avg. of 89.05. and higher than S&P 500 Avg. of 0.01
• More on AYTU's Valuation
|
|
Aytu Biopharma Inc net profit margin of 9.22 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 123 in Healthcare sector and number 1391 in S&P 500.
• More on AYTU's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com